• medical treatment

Treatment package for liver cancer by Transcatheter Arterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA)

implementation facility
  • Tokushukai Shonan-Kamakura General Hospital
address
  • 247-8533
  • Kanagawa1370-1, Okamoto, Kamakura city
Facility Details
program name
Treatment package for liver cancer by Transcatheter Arterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA)
genre
  • medical treatment:liver cancer
program details
[Medical condition] Hepatocellular carcinoma, Metastatic liver cancer [Special features] Transcatheter Arterial Chemoembolization (TACE) is a method in which anti-cancer drugs and embolus material (gelatin sponge) is injected into hepatic artery which provides nutrition to the tumor and the tumor falls into ischemic necrosis by embolizing feeding arteries. Even a large tumor or multiple tumors is treatable. Radiofrequency Ablation (RFA) is a method in which electrode needle is inserted to the center of the tumor through the skin while observing the tumor with ultrasound and by applying an electric current called radio wave, heats occurs around the needle leading to the necrosis of the tumor. Being different from surgical operation, the wound is just one needle width, and the necessity of rest after the treatment or the influence to the general condition is less. Re-treatment can be performed in several days. Improvement of treatment effect is expected by performing both therapies together.
[Clinical department]Treatment Center for Liver・Gallbladder・Pancreas Diseases, IVR center[Doctors in charge]Dr. Makoto Kako, graduated from Tokyo University, Faculty of Medicine, Ex-chief prof. of the 4th internal medicine department of Teikyo Univ. Ex-director of Social Insurance Tonan General Hospital, Ex-director of Fuchu Keijinnkai Hospital, Medical adviser authorized by the Japan Society of Hepatology, Medical specialist authorized by the Japanese Society of Gastroenterology, Medical adviser authorized by Japan Gastroenterological Endoscopy Society, Physician authorized by the Japanese Society of Internal Medicine, Ningen Dock specialist authorized by Japan Society of Ningen Dock. Dr. Takeshi Kinbara, graduated from Hamamatu Medical University in 1993. Medical specialist for liver authorized by the Japan Society of Hepatology, Medical specialist autholised by the Japanese Society of Gastroenterology, Physician authorized by the Japanese Society of Internal Medicine, Authorized doctor for cancer treatment, Member of Japan Gastroenterological Endoscopy Society. Dr Toshiki Tukiyama, graduated from Tokyo Medical Dental University, Chief of radiation diagnosis department, Chief of IVR center, Diagnosis specialist authorized by Japan Radiological Society, Specialist authorized by Japan IVR Society, Authorized doctor of image interpretation for Breast Cancer[Past record]Transcatheter Arterial Chemoembolization (TACE) 70 cases/year Radiofrequency Ablation (RFA) 21 cases/year
consultation day
月~土
requirement, condition for apply
[Conditions for accepting]Radiofrequency Ablation (RFA) ・Tumor size is less than 3cm in diameter, The number of tumor is less than 3. Transcatheter Arterial Chemoembolization (TACE) ・Tumor size is more than 3cm in diameter, The number of tumor is more than 4. ・People who is categorized in grade A or B by Child-Pugh classification for liver dysfunction. We will discuss with people of grade C. Even though the tumor redevelops, we can detect it early and it is possible to take both treatments again. Transcatheter arterial infusion (TAI) is performed as well. 〈Based on the information, we decide whether the patient is acceptable or not〉・Medical history・Blood examination data・Image (CT, MRI)
for more details information about this program,
kindly inquire from here
other program on this facility